[Newsmp] Alovogen and AstraZeneca had agreed not to release a generic version on condition of exclusive distribution rights for original drugs in Korea, and the Fair Trade Commission (FTC, Chairman Han Ki-jeong) imposed a corrective order and a fine.The FTC announced on the 13th that it had decided

[Newsmp] Foreign investors showed marked differences by stock in pharmaceutical stocks.Il Dong Pharmaceutical’s foreign ownership plunged by 4.57%p and Il Dong Holdings by 3.14%p, while Il-Yang Pharmaceutical, Samjin Pharmaceutical, and Bukwang Pharmaceutical also decreased by more than 1%p.Of the 3

[Newsmp] In the midst of the COVID-19 pandemic, individual investors who have been big fans of pharmaceutical stocks have lost their interest.According to the Korea Exchange, the sales of individual investors on 46 pharmaceutical stocks in the securities market were about KRW 472.6 billion, more tha

[Newsmp] Many of the pharmaceutical stocks plummeted in the third quarter, but there were also a number of stocks that entered the top stock price increase ranking.Stock prices of 50 out of 59 pharmaceutical-related stocks (including preferred stocks and holding stocks) fell in the securities market

[Newsmp] The global trend of endemic is reflected in the bio-health industry’s export performance.The bio-health industry’s exports in September fell 4.5% year-on-year to $1.328 billion, according to the Ministry of Trade, Industry and Energy.This year, exports of the bio-health industry recorded do

[Newsmp] In September, most of the pharmaceutical stocks dropped more than 10% amid repeated lethargy in the pharmaceutical index.According to the Kore Exchange, the pharmaceutical index has recently fallen to the pre-COVID-19 level, diving to the 12,000-point level.Of the 46 stocks, 41 companies fe

[Newsmp] The trade deficit of pharmaceutical products has fallen for the second consecutive month.On the other hand, diagnostic reagents that have expanded their surplus this year have decreased for two straight months.According to the Korea Customs Service, exports of pharmaceutical products (HS30)

[Newsmp] In the first half, the average sales of listed pharmaceutical and bio companies exceeded KRW 100 billion. (Closing accounts are in December, separate financial statements)According to Korean data provider FnGuide, a total of 148 pharmaceutical manufacturers posted about KRW 15.3333 trillion

[Newsmp] The debt-to-equity ratio of more than half of listed pharmaceutical companies rose in the first half. However, the average debt-to-equity ratio was still below 60%.Newsmp tallied the first half debt-to-equity ratio of 62 drug makers, whose closing accounts are in December, and found that th

[Newsmp] In August, foreign ownership of listed pharmaceutical companies showed a downward trend.According to the Korea Exchange, foreign ownership of 32 out of 46 stocks declined during this period.The range was not significant. Shin Poong Pharmaceutical was the only company whose foreign ownership

[Newsmp] In August, the number of drug patents registered by the Ministry of Food and Drug Safety (MFDS) exceeded 30.According to the MFDS information platform (https://nedrug.mfds.go.kr/), the number of patent registrations, which fell from 39 in May to 10 in June, increased to 29 in July, and rose

[Newsmp] While pharmaceutical stocks continued to struggle in August, most of the net purchases by investors were below KRW 10 billion.Institutions and foreigners largely bought Celltrion, but individuals sold heavily, showing a different trend.According to the Korea Exchange, institutional investor

[Newsmp] Bio-health industry exports turned to a negative growth trend in the second half when the endemic began while increasing steeply due to the global spread of omicron.According to the Ministry of Trade, Industry and Energy, monthly exports of the bio-health industry fell 0.02% year-on-year to

[Newsmp] In the first half of the year, six listed pharmaceutical and bio companies recorded a net profit of more than KRW 100 billion.Newsmp tallied the net profit of medicinal and pharmaceutical products manufacturers in the first half and found that three pharmaceutical companies left a net profi

[Newsmp] In the first half, 10 listed pharmaceutical companies achieved sales of more than half of their assets.Newsmp tallied the asset turnover of 62 Korean pharmaceutical companies in the first half and the average asset turnover was 0.37.The asset turnover of 10 companies exceeded 0.5, and Jeil

[Newsmp] In the second quarter, one-third of 44 pharmaceutical and bio companies, whose closing accounts are in December (excluding the financial industry), included in the pharmaceutical index recorded double-digit operating profit margins.In particular, both pharmaceutical and biotech companies th

[Newsmp] There is a dissimilarity in the trade balance between pharmaceutical products (HS30) and diagnostic reagents (HS3822).While the deficit of pharmaceutical products has decreased significantly in July, diagnostic reagents have shrunk in surplus.This year, exports of pharmaceutical products, i

[Newsmp] The gap between treatments for spinal muscular atrophy (SMA) is narrowing.Newsmp tallied the quarterly reports of three companies with SMA treatments Biogen, Novartis, and Roche, and found the semi-annual sales gap between three drugs, Spinraza (Biogen), Zolgensma (Novartis), and Evrysdi (R

[Newsmp] Ozempic (Novo Nordisk) has overtaken Trulicity (Lilly), which has been leading the injectable diabetes medicine market.As a result of Newsmp compiled the quarterly reports of major global big pharma, Novo Nordisk’s GLP-1 analogue, Ozempic, achieved sales of about KRW 2.6 trillion in the sec

[Newsmp] In the second quarter, the growth of global big pharma has shrunk as the Omicron variant peaked.As a result of Newsmp compiled the second-quarter reports of major global bigCompanies with COVID-19 vaccines and treatments continued to grow, but they also saw their growth shrink in the second